Honeywell International, Inc.
HON
$218.54
-0.26%
Honeywell International Inc. is a global multi-industry conglomerate operating through four core segments: aerospace technologies, industrial automation, energy and sustainability solutions, and building automation. The company is a market leader with one of the world's largest installed equipment bases, deriving significant recurring revenue from aftermarket services. The current investor narrative is dominated by the company's strategic portfolio transformation, including the planned spin-off of its aerospace unit and the recent divestiture of its Productivity business, which aims to unlock shareholder value but has introduced near-term uncertainty and overshadowed recent financial results.…
HON
Honeywell International, Inc.
$218.54
Related headlines
Investment Opinion: Should I buy HON Today?
Rating & Thesis: Hold. Honeywell is a 'show me' story where compelling long-term strategy is overshadowed by severe near-term financial deterioration and execution risk, making it prudent to wait for evidence of a turnaround before committing new capital. The lack of a clear analyst consensus target price underscores the current uncertainty.
Supporting Evidence: The primary valuation metric, the forward P/E of 18.5x, is reasonable if the company hits its average EPS estimate of $14.04, implying a forward earnings yield of ~5.4%. However, this is contingent on a dramatic recovery from Q4's net income of $295M. Revenue growth has turned negative (-3.3% YoY in Q4), and profitability is under severe pressure, with net margin collapsing to 3.0%. The strong TTM FCF of $5.39B and high ROE of 30.6% are positive offsets, indicating the underlying asset quality remains sound.
Risks & Conditions: The two biggest risks are the continuation of revenue/earnings declines and a botched execution of the portfolio transformation. This Hold rating would upgrade to a Buy if: 1) The post-spin-off 'New Honeywell' demonstrates sequential revenue growth and margin stabilization, or 2) The forward P/E compresses below 16x without a deterioration in the forward EPS outlook. It would downgrade to a Sell if: 1) Q4's earnings weakness proves not to be an anomaly and repeats in subsequent quarters, or 2) The stock breaks decisively below its 52-week low of $186.76 on high volume. Currently, the stock appears fairly valued relative to its challenged near-term prospects but could become undervalued if the transformation succeeds.
Sign up to view all
HON 12-Month Price Forecast
The AI assessment is neutral based on the high degree of binary outcome tied to Honeywell's corporate transformation. The significant disconnect between deteriorating fundamentals (negative revenue growth, collapsing net income) and the strategic promise of the spin-offs creates an uninvestable fog until clarity emerges. The substantial free cash flow and reasonable forward multiple provide a floor, but the lack of positive momentum in reported financials prevents a bullish stance. The stance would upgrade to bullish on consecutive quarters of sequential revenue and earnings improvement in the remaining core segments. It would downgrade to bearish if the stock breaks below $186 on high volume, signaling a failure of the 'value floor' thesis.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Honeywell International, Inc.'s 12-month outlook, with a consensus price target around $284.10 and implied upside of +30.0% versus the current price.
Average Target
$284.10
9 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
9
covering this stock
Price Range
$175 - $284
Analyst target range
Analyst coverage for Honeywell is substantial, with data indicating 9 analysts providing estimates, though a specific consensus recommendation and average target price are not provided in the dataset. The implied upside or downside cannot be calculated without an average target. Institutional ratings data shows recent activity is mixed but leans cautiously optimistic, with firms like Wolfe Research upgrading to 'Outperform' and Barclays, RBC Capital, and JP Morgan maintaining 'Overweight' or 'Buy' ratings, while Morgan Stanley and Wells Fargo have 'Equal Weight' stances. The range of analyst EPS estimates for the upcoming period is $13.73 to $14.32, with a revenue estimate range of $46.93 billion to $48.47 billion; this relatively tight range on EPS suggests some consensus on near-term profitability, while the revenue spread indicates greater uncertainty about top-line performance, reflecting the transitional nature of the business and the impact of divestitures.
Bulls vs Bears: HON Investment Factors
The investment debate for Honeywell is a classic clash between long-term strategic potential and near-term financial deterioration. The bear case currently holds stronger evidence, as concrete data points—a -3.3% revenue decline, a 3% net margin in Q4, and severe negative price momentum—are more immediate and impactful than the forward-looking strategic benefits. The single most important tension is whether the company's robust free cash flow generation and strategic portfolio actions can successfully arrest the earnings collapse and reignite growth before valuation multiples compress further. The resolution of this tension, visible in upcoming quarterly reports post-divestitures, will definitively shift the thesis.
Bullish
- Strong Free Cash Flow Generation: The company generated a robust $5.39 billion in trailing twelve-month free cash flow, providing ample liquidity to fund operations, dividends, and strategic portfolio moves. This financial strength underpins the company's ability to navigate its transformation.
- Attractive Forward Valuation: The forward P/E ratio of 18.5x is significantly lower than the trailing P/E of 26.4x, indicating the market expects a substantial earnings recovery. This forward multiple suggests a more reasonable valuation if the company meets its forward EPS estimates, which average $14.04.
- Strategic Portfolio Transformation: The planned spin-off of the Aerospace unit and recent divestiture of the Productivity business are strategic moves to unlock shareholder value and create more focused entities. This aligns with a long-term narrative of streamlining and capitalizing on secular growth trends in remaining segments.
- Solid Profitability Metrics: Despite recent volatility, the company maintains a strong Return on Equity of 30.6% and an operating margin of 17.5%. These metrics indicate the underlying business remains highly efficient at generating returns on shareholder capital.
Bearish
- Severe Revenue and Earnings Pressure: Q4 2025 revenue declined -3.3% YoY to $9.76B, and net income plummeted to $295M (a 3.0% margin) from $1.83B in Q3. This sharp deceleration and earnings collapse overshadow any strategic narrative and signal significant operational headwinds.
- High Financial Leverage: The debt-to-equity ratio of 2.24 indicates significant leverage on the balance sheet. This elevated debt load could constrain financial flexibility and amplify downside risk if interest rates remain elevated or earnings continue to weaken.
- Negative Momentum and Technical Downtrend: The stock is down -6.88% over the past month and -6.60% over three months, trading near 34% of its 52-week range. Its -16.96% maximum drawdown and severe underperformance vs. the SPY (-16.86% over 1 month) reflect strong negative sentiment and selling pressure.
- Execution and Transition Overhang: The planned Aerospace spin-off, while potentially value-creative long-term, introduces near-term uncertainty, complexity, and execution risk. This overhang is cited as a key reason recent earnings beats were ignored by the market, creating a 'show me' story.
HON Technical Analysis
The stock is in a pronounced downtrend from its recent highs, with the 1-year price change of +6.99% masking a significant recent correction. Currently trading at $212.50, the price sits at approximately 34% of its 52-week range ($186.76 to $248.18), indicating it is much closer to its yearly low than its high, which may signal a potential value opportunity but also reflects substantial negative momentum and investor anxiety. Recent momentum has been decisively negative, with the stock down -6.88% over the past month and -6.60% over the past three months, a stark divergence from the positive 1-year and 6-month (+5.55%) trends, signaling a significant short-term reversal likely driven by disappointing earnings and strategic uncertainty. Key technical support is at the 52-week low of $186.76, while resistance lies near the recent highs around $248.18; a breakdown below support could trigger further selling, while a recovery above resistance would require a major catalyst. With a beta of 0.915, the stock is slightly less volatile than the broader market, yet its recent -16.96% maximum drawdown and severe underperformance relative to the SPY over the past month (-16.86%) highlight its heightened idiosyncratic risk during this transition period.
Beta
0.81
0.81x market volatility
Max Drawdown
-17.0%
Largest decline past year
52-Week Range
$187-$248
Price range past year
Annual Return
+5.7%
Cumulative gain past year
| Period | HON Return | S&P 500 |
|---|---|---|
| 1m | -7.0% | +8.6% |
| 3m | -10.0% | +6.7% |
| 6m | +9.3% | +9.8% |
| 1y | +5.7% | +26.6% |
| ytd | +11.6% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HON Fundamental Analysis
Revenue growth has stalled and turned negative, with the most recent Q4 2025 revenue of $9.76 billion representing a -3.3% year-over-year decline, continuing a trend of deceleration from stronger growth in prior quarters of 2025. Segment data shows Aerospace ($8.69B) as the largest contributor, but the planned spin-off of this unit is a major near-term overhang on the overall growth narrative. Profitability remains intact but showed severe pressure in Q4, with net income plunging to $295 million (a net margin of 3.0%) from $1.83 billion in Q3, while the gross margin of 35.6% was stable sequentially but down from earlier quarters in the year, indicating potential cost pressures or mix issues impacting bottom-line results. The balance sheet and cash flow position is mixed, with a high debt-to-equity ratio of 2.24 indicating significant leverage, but the company generated robust trailing twelve-month free cash flow of $5.39 billion, providing ample liquidity to fund operations, dividends, and strategic moves; however, the sharp quarterly drop in free cash flow to $1.12 billion in Q4 and an ROE of 30.6% suggest the company is still generating solid returns on capital despite the earnings volatility.
Quarterly Revenue
$9.8B
2025-12
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.35%
Latest Quarter
Free Cash Flow
$5.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HON Overvalued?
Given the company's consistent profitability, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE stands at 26.4x, while the forward PE is notably lower at 18.5x, indicating the market expects a significant earnings recovery in the coming year, likely anticipating benefits from portfolio simplification post-spin-offs. Compared to sector averages, Honeywell's trailing PE of 26.4x and forward PE of 18.5x are not directly comparable without a provided industry average, but the forward multiple suggests a more reasonable growth-adjusted valuation if earnings estimates are met. Historically, the current trailing PE of 26.4x is below the peak levels seen in recent years (e.g., 105x in Q4 2025 due to depressed earnings) but is above the lower end of its historical band observed in 2022 and 2023, placing it in a mid-range that reflects balanced expectations amid the corporate transformation.
PE
26.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~105x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced, centered on severe earnings volatility and high leverage. The Q4 net income collapse to $295 million (from $1.83B in Q3) and a net margin of 3.0% demonstrate extreme bottom-line vulnerability, potentially due to cost pressures or one-time items related to the transformation. The debt-to-equity ratio of 2.24 signifies a leveraged balance sheet that could pressure the company if interest expenses rise or cash flow weakens, though the strong TTM FCF of $5.39B provides a near-term cushion. Revenue concentration in the to-be-spun-off Aerospace segment ($8.69B in Q4) also creates uncertainty about the growth profile of the remaining 'New Honeywell.'
Market & Competitive Risks include valuation compression and strategic execution missteps. With a forward P/E of 18.5x, the market is pricing in a significant earnings recovery; failure to deliver could lead to multiple contraction. The stock's beta of 0.915 suggests it is slightly less volatile than the market, but its severe recent underperformance (-16.86% vs. SPY over 1 month) indicates high idiosyncratic risk tied to the corporate breakup. Competitive risks are elevated as the company navigates a complex separation, potentially distracting management and allowing nimbler peers in automation and sustainability to gain share.
Worst-Case Scenario involves a 'broken transformation' narrative taking hold. This would entail the Aerospace spin-off failing to unlock expected value, the remaining businesses continuing to exhibit revenue declines and margin pressure, and rising interest costs straining the leveraged balance sheet. In this adverse scenario, the stock could re-test its 52-week low of $186.76, representing a downside of approximately -12% from the current price of $212.50. A break below that level could trigger further technical selling, potentially leading to a drawdown of -20% to -25% as investors lose confidence in the strategic plan.
FAQ
The key risks are, in order of severity: 1) Financial/Operational: Continuation of the severe earnings volatility seen in Q4 2025, where net income fell to $295M on a 3.0% margin. 2) Strategic/Execution: The complex spin-off of the Aerospace unit fails to create value, distracts management, or incurs higher-than-expected costs. 3) Financial Structure: The high debt-to-equity ratio of 2.24 could become burdensome if interest rates rise or cash flow weakens. 4) Market/Sentiment: Persistent negative momentum, as evidenced by the stock's -6.88% 1-month return and position near its 52-week low, could lead to further technical selling.
The 12-month forecast for HON is highly bifurcated, with a base case target range of $210-$235 (55% probability), a bull case of $248-$260 (25%), and a bear case of $186-$200 (20%). The base case, which is most likely, assumes the company stabilizes its financials and executes the spin-off without major hiccups, leading to modest upside. The key assumption is that Q4's earnings collapse is not repeated and net margins recover to the mid-teens. The forecast hinges almost entirely on the company's ability to demonstrate operational improvement in the coming quarters to justify its forward valuation.
HON appears fairly valued relative to its near-term challenged prospects but carries a risk of becoming overvalued if earnings do not recover. The trailing P/E of 26.4x is elevated for a company with negative growth, but the more relevant forward P/E of 18.5x implies the market expects a significant earnings rebound to an average EPS of $14.04. Compared to its own history, the valuation is in a mid-range, reflecting balanced expectations. The current price implies the market is paying a fair price for a successful transformation but offers little margin of safety if execution stumbles.
HON is not a compelling buy at the current moment for most investors. While the forward P/E of 18.5x appears reasonable and the strategic spin-off could unlock long-term value, the stock is a 'show me' story. Recent financials show severe pressure, with Q4 revenue down -3.3% and net income collapsing to $295 million. The biggest downside risk is that this operational weakness continues, invalidating the recovery priced into the forward multiple. It could become a good buy for patient, risk-tolerant investors if the post-spin-off entity demonstrates clear growth and margin recovery in the next two quarters.
HON is unsuitable for short-term trading due to its high event-driven volatility and lack of positive momentum. It is primarily a candidate for a long-term (3+ year) investment, but only for investors who believe in the strategic rationale of the portfolio transformation and are willing to endure significant uncertainty. The stock's beta of 0.915 suggests market-like volatility over time, but the current corporate actions introduce substantial idiosyncratic risk. The 2.4% dividend yield provides some income while waiting, but the suggested minimum holding period is through the completion of the Aerospace spin-off and at least two subsequent earnings reports from the new corporate structure.